Search Results

There are 12915 results for: content related to: Biliverdin inhibits hepatitis C virus nonstructural 3/4A protease activity: Mechanism for the antiviral effects of heme oxygenase?

  1. You have free access to this content
    AASLD Abstracts


    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  2. You have free access to this content
    Establishment of an indicator cell system for hepatitis C virus

    Microbiology and Immunology

    Volume 54, Issue 4, April 2010, Pages: 206–220, Yoshinori Tanaka, Yoshio Mori, Hideki Tani, Takayuki Abe, Kohji Moriishi, Hirotatsu Kojima, Tetsuo Nagano, Takayoshi Okabe, Tetsuro Suzuki, Masashi Tatsumi and Yoshiharu Matsuura

    Version of Record online : 12 MAR 2010, DOI: 10.1111/j.1348-0421.2010.00209.x

  3. Hepatitis C virus NS2 protease inhibits host cell antiviral response by inhibiting IKKε and TBK1 functions

    Journal of Medical Virology

    Volume 85, Issue 1, January 2013, Pages: 71–82, Pasi Kaukinen, Maarit Sillanpää, Laura Nousiainen, Krister Melén and Ilkka Julkunen

    Version of Record online : 23 OCT 2012, DOI: 10.1002/jmv.23442

  4. Discovery and Development of the HCV NS3/4A Protease Inhibitor Danoprevir (ITMN-191/RG7227)

    Antiviral Drugs: From Basic Discovery through Clinical Trials

    Scott D. Seiwert, Karl Kossen, Lin Pan, Jyanwei Liu, Brad O. Buckman, Pages: 257–271, 2011

    Published Online : 20 JUN 2011, DOI: 10.1002/9780470929353.ch18

  5. You have free access to this content
    Anti–tumor necrosis factor α treatment promotes apoptosis and prevents liver regeneration in a transgenic mouse model of chronic hepatitis C


    Volume 52, Issue 5, November 2010, Pages: 1553–1563, Erwin Daniel Brenndörfer, Malin Weiland, Lars Frelin, Emma Derk, Gustaf Ahlén, Jian Jiao, Johannes Georg Bode and Matti Sällberg

    Version of Record online : 29 OCT 2010, DOI: 10.1002/hep.23870

  6. You have free access to this content
    Nonstructural 3/4A protease of hepatitis C virus activates epithelial growth factor–induced signal transduction by cleavage of the T-cell protein tyrosine phosphatase


    Volume 49, Issue 6, June 2009, Pages: 1810–1820, Erwin Daniel Brenndörfer, Juliane Karthe, Lars Frelin, Patricia Cebula, Andreas Erhardt, Jan Schulte am Esch, Hartmut Hengel, Ralf Bartenschlager, Matti Sällberg, Dieter Häussinger and Johannes Georg Bode

    Version of Record online : 23 JAN 2009, DOI: 10.1002/hep.22857

  7. You have free access to this content
    Limited suppression of the interferon-β production by hepatitis C virus serine protease in cultured human hepatocytes

    The FEBS Journal

    Volume 274, Issue 16, August 2007, Pages: 4161–4176, Hiromichi Dansako, Masanori Ikeda and Nobuyuki Kato

    Version of Record online : 25 JUL 2007, DOI: 10.1111/j.1742-4658.2007.05942.x

  8. You have free access to this content
    Andrographolide exerts anti-hepatitis C virus activity by up-regulating haeme oxygenase-1 via the p38 MAPK/Nrf2 pathway in human hepatoma cells

    British Journal of Pharmacology

    Volume 171, Issue 1, January 2014, Pages: 237–252, Jin-Ching Lee, Chin-Kai Tseng, Kung-Chia Young, Hung-Yu Sun, Shainn-Wei Wang, Wei-Chun Chen, Chun-Kuang Lin and Yu-Hsuan Wu

    Version of Record online : 10 DEC 2013, DOI: 10.1111/bph.12440

  9. The NS3/4A proteinase of the hepatitis C virus: unravelling structure and function of an unusual enzyme and a prime target for antiviral therapy

    Journal of Viral Hepatitis

    Volume 6, Issue 3, May 1999, Pages: 165–181, R. Bartenschlager

    Version of Record online : 28 FEB 2002, DOI: 10.1046/j.1365-2893.1999.00152.x

  10. Importin β1 targeting by hepatitis C virus NS3/4A protein restricts IRF3 and NF-κB signaling of IFNB1 antiviral response


    Volume 18, Issue 6, June 2017, Pages: 362–377, Bridget Gagné, Nicolas Tremblay, Alex Y. Park, Martin Baril and Daniel Lamarre

    Version of Record online : 2 MAY 2017, DOI: 10.1111/tra.12480

  11. You have free access to this content
    The effect of prime-site occupancy on the hepatitis C virus NS3 protease structure

    Protein Science

    Volume 11, Issue 9, September 2002, Pages: 2102–2112, Annarita Casbarra, Fabrizio Dal Piaz, Paolo Ingallinella, Stefania Orrù, Piero Pucci, Antonello Pessi and Elisabetta Bianchi

    Version of Record online : 13 APR 2009, DOI: 10.1110/ps.0206602

  12. Nonstructural protein 3-4A: the Swiss army knife of hepatitis C virus

    Journal of Viral Hepatitis

    Volume 18, Issue 5, May 2011, Pages: 305–315, K. Morikawa, C. M. Lange, J. Gouttenoire, E. Meylan, V. Brass, F. Penin and D. Moradpour

    Version of Record online : 23 MAR 2011, DOI: 10.1111/j.1365-2893.2011.01451.x

  13. You have free access to this content
    The interdomain interface in bifunctional enzyme protein 3/4A (NS3/4A) regulates protease and helicase activities

    Protein Science

    Volume 22, Issue 12, December 2013, Pages: 1786–1798, Cihan Aydin, Sourav Mukherjee, Alicia M. Hanson, David N. Frick and Celia A. Schiffer

    Version of Record online : 19 OCT 2013, DOI: 10.1002/pro.2378

  14. Mechanistic role of NS4A and substrate in the activation of HCV NS3 protease

    Proteins: Structure, Function, and Bioinformatics

    Volume 79, Issue 8, August 2011, Pages: 2428–2443, Haimei Zhu and James M. Briggs

    Version of Record online : 1 JUN 2011, DOI: 10.1002/prot.23064

  15. Recent Advances in Hepatitis C Therapies

    Standard Article

    Burger's Medicinal Chemistry and Drug Discovery

    Bloom Jonathan, Zapf Christoph, Levin Jeremy and Flint Michael

    Published Online : 15 SEP 2010, DOI: 10.1002/0471266949.bmc238

  16. You have free access to this content
    Hepatitis C virus NS4B protein targets STING and abrogates RIG-I–mediated type I interferon-dependent innate immunity


    Volume 57, Issue 1, January 2013, Pages: 46–58, Sayuri Nitta, Naoya Sakamoto, Mina Nakagawa, Sei Kakinuma, Kako Mishima, Akiko Kusano-Kitazume, Kei Kiyohashi, Miyako Murakawa, Yuki Nishimura-Sakurai, Seishin Azuma, Megumi Tasaka-Fujita, Yasuhiro Asahina, Mitsutoshi Yoneyama, Takashi Fujita and Mamoru Watanabe

    Version of Record online : 7 JAN 2013, DOI: 10.1002/hep.26017

  17. You have free access to this content
    Review article: specifically targeted anti-viral therapy for hepatitis C – a new era in therapy

    Alimentary Pharmacology & Therapeutics

    Volume 32, Issue 1, July 2010, Pages: 14–28, C. M. Lange, C. Sarrazin and S. Zeuzem

    Version of Record online : 31 MAR 2010, DOI: 10.1111/j.1365-2036.2010.04317.x

  18. You have free access to this content
    Quantitative proteomics identifies the membrane-associated peroxidase GPx8 as a cellular substrate of the hepatitis C virus NS3-4A protease


    Volume 59, Issue 2, February 2014, Pages: 423–433, Kenichi Morikawa, Jérôme Gouttenoire, Céline Hernandez, Viet Loan Dao Thi, Huong T.L. Tran, Christian M. Lange, Michael T. Dill, Markus H. Heim, Olivier Donzé, François Penin, Manfredo Quadroni and Darius Moradpour

    Version of Record online : 18 DEC 2013, DOI: 10.1002/hep.26671

  19. Inhibiting viral proteases: Challenges and opportunities

    Peptide Science

    Volume 66, Issue 2, 2002, Pages: 101–114, Elisabetta Bianchi and Antonello Pessi

    Version of Record online : 16 SEP 2002, DOI: 10.1002/bip.10230

  20. You have free access to this content
    Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus–infected patients


    Volume 50, Issue 6, December 2009, Pages: 1709–1718, Simone Susser, Christoph Welsch, Yalan Wang, Markus Zettler, Francisco S. Domingues, Ursula Karey, Eric Hughes, Robert Ralston, Xiao Tong, Eva Herrmann, Stefan Zeuzem and Christoph Sarrazin

    Version of Record online : 4 AUG 2009, DOI: 10.1002/hep.23192